The War on Trans Healthcare Is Not About Science What a study of 957 detransitioners revealed, and why Washington gets it wrong, with Dr. Kinnon Ross MacKinnon cover art

The War on Trans Healthcare Is Not About Science What a study of 957 detransitioners revealed, and why Washington gets it wrong, with Dr. Kinnon Ross MacKinnon

The War on Trans Healthcare Is Not About Science What a study of 957 detransitioners revealed, and why Washington gets it wrong, with Dr. Kinnon Ross MacKinnon

Listen for free

View show details
Trans healthcare is an evolving discussion, and the implications greatly affect those in the LGBTQ+ community. At its heart, this is a conversation about the science meant to inform transition-related healthcare care, and what happens when politics deliberately distorts it. On March 31, 2026, The Supreme Court handed down an 8-to-1 ruling that conversion therapy, a practice every major medical and mental health organization has condemned as harmful and without scientific basis, now qualifies as “protected speech” under the First Amendment. The case, Chiles v. Salazar, centered on a Christian counselor in Colorado who argued that a state ban on the practice violated her right to speak freely with her clients. Justice Neil Gorsuch, writing for the majority, declared that the First Amendment “stands as a shield against any effort to enforce orthodoxy in thought or speech in this country.” Only Justice Jackson dissented, warning that the ruling “misreads our precedents, is unprincipled and unworkable.” This decision puts laws in 23 states and the District of Columbia at serious risk. It tells LGBTQ+ young people that any licensed therapist with a personal ideological or religious agenda now has the constitutional right to try to change who they are. It arrived on a day meant to celebrate trans lives. This ruling lands in the same moment that Professor Kinnon Ross MacKinnon, a trans researcher whose work I deeply respect, published in the New York Times that the Trump administration has been weaponizing detransition research to justify bans on gender-affirming care. At the same time, his guest essay outlines the complexities of gender fluidity that can occur after accessing medical treatments for gender dysphoria. Early studies from the 1970s through the 2000s found detransition rates of roughly 1 to 6 percent, primarily among adult transgender women who had full surgical transitions. New research focusing on younger populations, though, identifies that between 2-17% [GU1] of young LGBTQ+ people may experience a detransition process. The field of pediatric gender-affirming healthcare, when it was rapidly scaled up in the United States and Canada over the last 10-15 years, was not prepared for the question of detransition and how to care for these experiences. Learn more about your ad choices. Visit megaphone.fm/adchoices
adbl_web_anon_alc_button_suppression_t1
No reviews yet